Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2025 10:00 ET | Source: Dewpoint Therapeutics

FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Dewpoint Therapeutics' DPTX3186